Clinicians develop model to calculate patient risk for NAFLD decompensation
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is associated with conditions such as obesity and metabolic syndrome,…
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is associated with conditions such as obesity and metabolic syndrome,…
Previous studies have found that manipulating renal nerves could serve as a hypertension therapeutic in cases where pharmacological treatment is ineffective. Sailesh Harwani, MD, PhD,…
Frank Faraci, PhD, Professor in the Division of Cardiovascular Medicine and of Pharmacology, received a five-year, $2.54M R01 grant from the National Institutes of Health…